# Acetyl-L-Carnitine in the Treatment of Septic Shock

> **NCT00592488** · PHASE1,PHASE2 · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 13 (actual)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Acetyl-L-Carnitine

## Key facts

- **NCT ID:** NCT00592488
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2009-08
- **Final completion:** 2009-09
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2017-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00592488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00592488, "Acetyl-L-Carnitine in the Treatment of Septic Shock". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00592488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*